Division of Cardiology, A.O.U. Policlinico “G. Rodolico‑San Marco,” University of Catania, Catania, Italy
Division of Cardiology, A.O.U. Policlinico “G. Rodolico‑San Marco,” University of Catania, Catania, Italy.
Kardiol Pol. 2020 Oct 23;78(10):967-973. doi: 10.33963/KP.15537. Epub 2020 Jul 29.
Intravascular administration of contrast media is an irreplaceable step of percutaneous coronary intervention. Since the latter is a very common procedure, contrast‑induced acute kidney injury (CI‑AKI) has become one of the most frequent causes of acute nephropathy, and a relevant prognostic impact of CI‑AKI has been observed. Some patient comorbidities and procedural characteristics have been identified as key risk factors of CI‑AKI. In this review, we discuss current evidence and future research directions on CI‑AKI prevention in patients undergoing percutaneous coronary intervention.
血管内给予造影剂是经皮冠状动脉介入治疗不可或缺的步骤。由于后者是一种非常常见的程序，造影剂引起的急性肾损伤（CI-AKI）已成为急性肾病最常见的原因之一，并且观察到 CI-AKI 具有相关的预后影响。一些患者合并症和程序特征已被确定为 CI-AKI 的关键危险因素。在这篇综述中，我们讨论了当前关于经皮冠状动脉介入治疗患者预防 CI-AKI 的证据和未来研究方向。
